Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | CPI-818 |
| Trade Name | |
| Synonyms | CPI818|CPI 818|Soquelitinib |
| Drug Descriptions |
CPI-818 inhibits IL-2 inducible T-cell kinase (ITK), which may lead to inhibition of TCR signaling and growth of T cells (Cancer Res 2019;79(13 Suppl):Abstract nr 1313). |
| DrugClasses | |
| CAS Registry Number | 2226636-04-8 |
| NCIT ID | C162010 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| CPI-818 | CPI-818 | 0 | 2 |